EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines

Satish Kumar, Joanne E Curran, Erika C Espinosa, David C Glahn, John Blangero

Journal of Biological Methods · 08.01.2020 · 7 (1) · 1

DOI: 10.14440/jbm.2020.296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Methods, online erschienen am 08.01.2020. Verfasst von Satish Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics & South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Edinburg and Bro…. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue culture based in-vitro experimental modeling of human inherited disorders provides insight into the cellular and molecular mechanisms involved and the underlying genetic component influencing the disease phenotype. The breakthrough development of induced pluripotent stem cell (iPSC) technology represents a quantum leap in experimental modeling of human diseases, providing investigators with a self-renewing and thus unlimited source of pluripotent cells for targeted differentiation into functionally relevant disease specific tissue/cell types. The existing rich bio-resource of Epstein-Barr virus (EBV) immortalized lymphoblastoid cell line (LCL) repositories generated from a wide array of patients in genetic and epidemiological studies worldwide, many of them with extensive genotypic, genomic and phenotypic data already existing, provides a great opportunity to reprogram iPSCs from any of these LCL donors in the context of their own genetic identity for disease modeling and disease gene identification. However, due to the low reprogramming efficiency and poor success rate of LCL to iPSC reprogramming, these LCL resources remain severely underused for this purpose. Here, we detailed step-by-step instructions to perform our highly efficient LCL-to-iPSC reprogramming protocol using EBNA1/OriP episomal plasmids encoding pluripotency transcription factors (i.e., OCT3/4, SOX2, KLF4, L-MYC, and LIN28), mouse p53DD (p53 carboxy-terminal dominant-negative fragment) and commercially available reprogramming media. We achieved a consistently high reprogramming efficiency and 100% success rate (> 200 reprogrammed iPSC lines) using this protocol.

Schlagwörter

Stichwörter der Autor:innen

disease geneticsdisease modelinghumaniPSC reprogramminglymphoblastoid cell line

Autor:innen und Institutionen

  • Department of Human Genetics & South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Edinburg and Brownsville, TX 78541, USA.
  • Olin Neuropsychiatry Research Center, The Institute of Living, Hartford, CT 06106, USA.
  • Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.

Förderung

  • NCRR NIH HHS

Zitieren

APA

Kumar, S., Curran, J. E., Espinosa, E. C., Glahn, D. C., & Blangero, J. (2020). Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines. Journal of Biological Methods, 7(1), 1. https://doi.org/10.14440/jbm.2020.296

Vancouver

Kumar S, Curran JE, Espinosa EC, Glahn DC, Blangero J. Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines. Journal of Biological Methods. 2020;7(1):1. doi:10.14440/jbm.2020.296

BibTeX
@article{Kumar2020,
  author = {Kumar, Satish and Curran, Joanne E and Espinosa, Erika C and Glahn, David C and Blangero, John},
  title = {Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines},
  journal = {Journal of Biological Methods},
  year = {2020},
  volume = {7},
  number = {1},
  pages = {1},
  doi = {10.14440/jbm.2020.296}
}
Kostenlos starten →